+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Oncology Nutrition Market Outlook 2026-2034: by Cancer Type (Head & Neck Cancer, Stomach & Gastrointestinal Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Other Cancers), Formula Type, Nutrition Type, End User

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6243233
UP TO OFF until Jan 01st 2027
The Oncology Nutrition Market is estimated at US$3 billion in 2026 and is projected to grow at a CAGR of 6.4% to reach US$4.9 billion by 2034.

Market Overview

The Oncology Nutrition Market covers nutritional products and care solutions designed to support cancer patients through treatment, recovery, symptom management, and improved overall health status.

Relevant uses and settings include hospital nutrition support, oral supplements, recovery care, supportive oncology services, home nutrition management, and specialty diet planning. Commercial considerations include patient appetite variability, reimbursement limits, product tolerance differences, and need for evidence based integration into complex care pathways.

Market Segmentation

By Cancer Type

  • Head & Neck Cancer
  • Stomach & Gastrointestinal Cancer
  • Blood Cancer
  • Breast Cancer
  • Lung Cancer
  • Other Cancers

By Formula Type

  • Standard Formula
  • Elemental / Semi-elemental Formula
  • Disease-specific / Immunonutrition Formula

By Nutrition Type

  • Enteral Nutrition
  • Parenteral Nutrition

By End User

  • Hospitals
  • Home Care Settings
  • Specialty Oncology Clinics

Key Companies Analysed

  • Danone
  • Nestle Health Science
  • Abbott
  • Fresenius Kabi
  • Meiji Holdings
  • Ajinomoto
  • Kate Farms
  • Victus
  • Global Health Products
  • Smartfish
  • Hormel Health Labs
  • Baxter
  • B. Braun
  • Sichuan Kelun
  • Nutricia
  • Otsuka
  • Targeted Medical Pharma
  • SFI Health
  • Pfizer
  • Sandoz

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Oncology Nutrition Market Overview
2.1. Oncology Nutrition Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Oncology Nutrition Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Oncology Nutrition Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Oncology Nutrition Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
5.2. Oncology Nutrition Market Analysis By Cancer Type, 2025-2034
5.2.1. Head & Neck Cancer
5.2.2. Stomach & Gastrointestinal Cancer
5.2.3. Blood Cancer
5.2.4. Breast Cancer
5.2.5. Lung Cancer
5.2.6. Other Cancers
5.3. Oncology Nutrition Market Analysis By Formula Type, 2025-2034
5.3.1. Standard Formula
5.3.2. Elemental / Semi-elemental Formula
5.3.3. Disease-specific / Immunonutrition Formula
5.4. Oncology Nutrition Market Analysis By Nutrition Type, 2025-2034
5.4.1. Enteral Nutrition
5.4.2. Parenteral Nutrition
5.5. Oncology Nutrition Market Analysis By End User, 2025-2034
5.5.1. Hospitals
5.5.2. Home Care Settings
5.5.3. Specialty Oncology Clinics
6. North America Oncology Nutrition Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Oncology Nutrition Market Analysis By Cancer Type
6.3. North America Oncology Nutrition Market Analysis By Formula Type
6.4. North America Oncology Nutrition Market Analysis By Nutrition Type
6.5. North America Oncology Nutrition Market Analysis By End User
6.6. North America Outlook By Country
6.6.1. United States
6.6.2. Canada
6.6.3. Mexico
7. Europe Oncology Nutrition Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Oncology Nutrition Market Analysis By Cancer Type
7.3. Europe Oncology Nutrition Market Analysis By Formula Type
7.4. Europe Oncology Nutrition Market Analysis By Nutrition Type
7.5. Europe Oncology Nutrition Market Analysis By End User
7.6. Europe Outlook By Country
7.6.1. Germany
7.6.2. United Kingdom
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Netherlands
7.6.7. Switzerland
7.6.8. Poland
7.6.9. Sweden
7.6.10. Russia
8. Asia-Pacific Oncology Nutrition Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Oncology Nutrition Market Analysis By Cancer Type
8.3. Asia-Pacific Oncology Nutrition Market Analysis By Formula Type
8.4. Asia-Pacific Oncology Nutrition Market Analysis By Nutrition Type
8.5. Asia-Pacific Oncology Nutrition Market Analysis By End User
8.6. Asia-Pacific Outlook By Country
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Australia
8.6.6. Indonesia
8.6.7. Malaysia
8.6.8. Vietnam
9. Middle East and Africa Oncology Nutrition Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Oncology Nutrition Market Analysis By Cancer Type
9.3. Middle East and Africa Oncology Nutrition Market Analysis By Formula Type
9.4. Middle East and Africa Oncology Nutrition Market Analysis By Nutrition Type
9.5. Middle East and Africa Oncology Nutrition Market Analysis By End User
9.6. Middle East and Africa Outlook By Country
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Egypt
10. South and Central America Oncology Nutrition Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Oncology Nutrition Market Analysis By Cancer Type
10.3. South and Central America Oncology Nutrition Market Analysis By Formula Type
10.4. South and Central America Oncology Nutrition Market Analysis By Nutrition Type
10.5. South and Central America Oncology Nutrition Market Analysis By End User
10.6. South and Central America Outlook By Country
10.6.1. Brazil
10.6.2. Argentina
10.6.3. Chile
10.6.4. Peru
11. Oncology Nutrition Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Danone
11.2.2. Nestle Health Science
11.2.3. Abbott
11.2.4. Fresenius Kabi
11.2.5. Meiji Holdings
11.2.6. Ajinomoto
11.2.7. Kate Farms
11.2.8. Victus
11.2.9. Global Health Products
11.2.10. Smartfish
11.2.11. Hormel Health Labs
11.2.12. Baxter
11.2.13. B. Braun
11.2.14. Sichuan Kelun
11.2.15. Nutricia
11.2.16. Otsuka
11.2.17. Targeted Medical Pharma
11.2.18. SFI Health
11.2.19. Pfizer
11.2.20. Sandoz
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Danone
  • Nestle Health Science
  • Abbott
  • Fresenius Kabi
  • Meiji Holdings
  • Ajinomoto
  • Kate Farms
  • Victus
  • Global Health Products
  • Smartfish
  • Hormel Health Labs
  • Baxter
  • B. Braun
  • Sichuan Kelun
  • Nutricia
  • Otsuka
  • Targeted Medical Pharma
  • SFI Health
  • Pfizer
  • Sandoz

Table Information